Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery

Advanced Drug Delivery Reviews

Volumn 54, Issue 2, 2002, Pages 169-190

  Lavasanifar, Afsaneh ^a   Samuel, John ^a   Kwon, Glen S ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Block copolymer micelles; Conjugates; Drug delivery; Encapsulation; Passive drug targeting; Poly(ethylene oxide); Poly(L amino acid); Water insoluble drugs

Indexed keywords

AMINO ACIDS; COPOLYMERS; MICELLES; VIRUSES;

DRUG DELIVERY;

DRUG THERAPY;

COPOLYMER; DRUG CARRIER; LIPOPROTEIN; MACROGOL DERIVATIVE; POLYMER; SURFACTANT; WATER;

ARTICLE; BIOCOMPATIBILITY; CHEMICAL MODIFICATION; CHEMICAL PARAMETERS; COMPLEX FORMATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; HALF LIFE TIME; MICELLE; MORPHOLOGY; PRIORITY JOURNAL; SAFETY; SCALE UP; SOLUBILITY; VIRUS;

ANIMALS; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; EPOXY COMPOUNDS; HUMANS; MICELLES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POLYESTERS; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 0037148656     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00015-7     Document Type: Article

References (138)

1. Block copolymer micelles as vehicles for drug delivery
2. Block copolymers as drug carriers
3. Design of nanoscopic vehicles for drug targeting based on micellization of block copolymers
4. Block copolymer micelles as long circulating drug vehicles
5. Targetable drug carriers: Present status and a future perspective
6. Polymeric micelles as new drug carriers
7. Diblock copolymer nanoparticles for drug delivery
8. Nano-engineering block copolymer aggregates for drug delivery
9. Copolymer drug carriers: Conjugates, micelles and microspheres
10. Interpolyelectrolyte and block ionomer complexes for gene delivery: Physico-chemical aspects
11. Polymeric micelles - A new generation of colloidal drug carriers
12. Structure and design of polymeric surfactant-based drug delivery systems
13. Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution
14. Long circulating microparticulate drug carriers
15. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes
16. Delivery of molecular and cellular medicine to solid tumors
17. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tunor xenograft
18. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
19. A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainerrs for drug targeting from blood in brain
20. A novel reactive polymeric micelle with aldehyde groups on its surfaces
21. Surface charge modulation of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles: Conjugation of charged peptides
22. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells
23. Biodegradable block copolymers as injectable drug delivery systems
24. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs
25. Block copolymer micelles for drug delivery: Design, characterization and biological significance
26. Preparation of micelle-forming polymer-drug conjugates
27. Introduction of cisplatin into polymeric micelle
28. Micelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates
29. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size
30. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor
31. Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates
32. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release
33. Toxicological evaluation of poloxamer vehicles for intramuscular use
34. Biodegradable soluble macromolecules as drug carriers
35. Lysosomal degradability of poly(α-amino acids)
36. Poly(amino acid) copolymers as potential soluble drug delivery system. 2. Body distribution and preliminary biocompatibility testing in vitro and in vivo
37. Poly(L-lysine) and poly(D-lysine) conjugates of methotrexate: Different inhibitory effect on drug resistant cells
38. Immunological problems of polymer-bound drugs
39. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(β benzyl L-aspartate)
40. Clonazepam release from core-shell type nanoparticles in vitro
41. Norfloxacin release from polymeric micelle of poly(γ benzyl L-glutamate)/poly(ethylene oxide)/poly(γ benzyl L-glutamate) block copolymer
42. New macromolecular carriers for drugs, I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates
43. Light scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution
44. Liposomes designed to avoid the reticuloendothelial system
45. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: Biodistribution and therapeutic efficacy
46. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies
47. Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers
48. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
49. Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption
50. Micelle-forming block copolymers: Pinocytosis by macrophages and interaction with model membranes
51. Application of novel biomaterials in colloid drug delivery systems
52. Biodegradable long-circulating nanospheres
53. Thermo-responsive self assembled polymeric micelles for drug delivery in vitro
54. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible micelle forming systems
55. Cryo-TEM and SANS microstructural study of pluronic polymer solution
56. The reactive polymeric micelles based on an aldehyde-ended poly(ethylene glycol)/poly(lactide) block copolymer
57. Structural properties of self assembled polymeric micelles
58. Unusual selectivity in solubilization by block copolymer micelles
59. Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles
60. Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene-propylene oxide) block copolymer micelles: Effects of polymer structure
61. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl L-aspartate) block copolymer micelles
62. Fluorescence studies of amphiphilic poly(methacrylic acid)-block-polystyrene-block-poly(methacrylic acid) micelles
63. Block copolymer micelles for drug delivery: Loading and release of doxorubicin
64. Physical entrapment of adriamycin in AB block copolymer micelles
65. Novel PDLLA/PEG copolymer micelles as drug carriers
66. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestostrone
67. Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. Micelle formation and drug release behavior
68. Release kinetics studies of aromatic molecules into water from block copolymer micelles
69. Solubilization of aromatic solutes in block copolymers
70. The effect of surfactants on the aggregation state of amphotericin B
71. Soluble self-assembled block copolymers for drug delivery
72. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents
73. Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents fk506 and l-685,818
74. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers
75. Anthracycline antibiotics noncovalently incorporated into the block copolymer micelles: In vivo evaluation of anticancer activity
76. Micellar carriers for therapeutic and diagnostic agents
77. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs
78. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers
79. Reduction of the in vitro hemolytic activity of soybean lecithin liposomes by treatment with a block copolymer
80. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles
81. Kinetic studies on the stability of indomethacin in alkaline aqueous solutions containing poly(oxyethylene)poly(oxypropylene) surface active block copolymers
82. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes
83. The adjuvant activity of nonionic block polymer surfactants
84. The adjuvant activity of nonionic block copolymer surfactants
85. Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system
86. Defining the drug incorporation properties of PLA-PEG nanoparticles
87. Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxol
88. Development of amphiphilic diblock copolymers as micellar carriers of taxol
89. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel
90. Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers
91. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar taxol
92. Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization
93. PCL-b-PEO micelles as a delivery vehicle for FK506: Assessment of a functional recovery of crushed peripheral nerve
94. Amphiphilic diblock copolymer nanospheres composed of methoxy poly(ethylene glycol) and glycolide: Properties, cytotoxicity and drug release behavior
95. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer
96. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers
97. Preparation of non-fouling surface through the coating with core-polymerized block copolymer micelles having aldehyde-ended PEG shell
98. Sugar-installed polymer micelles: Synthesis and micellization of poly(ethylene glycol)-poly(DL-lactide) block copolymers having sugar groups at the PEG chain end
99. Functional and site-specific macromolecular micelles as high potential drug carriers
100. Polymeric antitumor agents on a molecular and cellular level
101. Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
102. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
103. Characterization and anticancer activity of the micelle forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer
104. Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography
105. Biodistribution of micelle-forming polymer-drug conjugates
106. Polymeric micelles as novel drug carriers and virus mimicking vehicles
107. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood
108. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates
109. Composition-dependent in vivo antitumor activity of adriamycin-conjugated polymeric micelle against murine colon adenocarcinoma
110. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin
111. Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(α,β-aspartic acid) block copolymer in an aqueous medium
112. Cisplatin-incorporated polymeric micelles reducing nephrotoxicity, while maintaining antitumor activity
113. Development of cisplatin-loaded polymeric micelles with a prolonged circulation in the bloodstream and an enhanced accumulation in the solid tumor
114. Coupling of steroid hormones to biodegradable poly (α-amino acids) I: Norethindrone coupled to poly-N5-(3-hydroxypropyl)-L-glutamine
115. Block copolymer micelles as vehicles for hydrophobic drugs
116. Pluronic P85 enhances the delivery of digoxin to the brain: In vitro and in vivo studies
117. Potential applications of polymers in the delivery of drugs to the central nervous system
118. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system
119. Roles of adriamycin and adriamycin dimer in antitumor activity of the polymeric micelle carrier system
120. Visualization of PEO-PBLA-pyrene polymeric micelles by atomic force microscopy
121. Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance
122. Reduction of the side effects of an antitumor agent KRN5500, by incorporation of the drug into polymeric micelles
123. Polymeric micelles for drug delivery: Solubilization and hemolytic activity of amphotericine B
124. Dissociated toxicity, but enhanced antifungal efficacy of amphotericin B loaded poly(ethylene oxide)-block-poly(β-benzyl L aspartate) micelles
125. Micelles of poly(ethylene oxide)-block-poly(hydroxy alkyl L-aspartamide): Synthetic analogues of lipoproteins for drug delivery
126. The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives
127. Soluble stoichiometric complexes from poly(N-ethyl-4-vinylpyridinium) cations and poly(ethylene oxide)-block-polymethacrylate anions
128. Block and graft copolymers and nanogel copolymer networks for DNA delivery into cell
129. Formation of stable and monodispersive polyion complex micelles in aqueous medium from poly(L-lysine) and poly(ethylene glycol)-poly(aspartic acid) block copolymer
130. Chain length recognition: Core-shell supramolecular assembly from oppositely charged block copolymers
131. Water soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer
132. Novel polyion complex micelles entrapping enzyme molecules in the core: Preparation of narrowly distributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium
133. Novel polyion complex micelles entrapping enzyme molecules in the core. [II]: Characterization of the micelles prepared at non-stoichiometric mixing ratios
134. Cationic copolymers for DNA delivery